{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:28:07Z","timestamp":1766759287041,"version":"3.48.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,26]]},"DOI":"10.7759\/cureus.100124","type":"journal-article","created":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:23:55Z","timestamp":1766759035000},"source":"Crossref","is-referenced-by-count":0,"title":["Outcomes and Toxicity of Stereotactic Radiotherapy in Non-small Cell Lung Cancer Patients With Interstitial Lung Disease: A Multicentre Cohort Study"],"prefix":"10.7759","author":[{"given":"Alexander J","family":"Sherlock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalise M","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harry E","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antony","family":"Carver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sundus","family":"Yahya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.4065\/83.5.584","article-title":"Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina JR","year":"2008","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clin Proc. 2008, 83:584-94. 10.4065\/83.5.584","journal-title":"Mayo Clin Proc"},{"key":"ref2","unstructured":"WHO. Cancer. (2025). Accessed. May 1, 2025: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/cancer."},{"key":"ref3","unstructured":"WCR Fund. Lung Cancer Statistics. (2025). Accessed. May 1, 2025: https:\/\/www.wcrf.org\/preventing-cancer\/cancer-statistics\/lung-cancer-statistics\/."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-021-02108-2","article-title":"Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050","volume":"27","author":"Sharma R","year":"2022","unstructured":"Sharma R. Mapping of global, regional and national incidence, mortality and mortality-to-incidence ratio of lung cancer in 2020 and 2050. Int J Clin Oncol. 2022, 27:665-75. 10.1007\/s10147-021-02108-2","journal-title":"Int J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2016.10.010","article-title":"The eighth edition lung cancer stage classification","volume":"151","author":"Detterbeck FC","year":"2017","unstructured":"Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The eighth edition lung cancer stage classification. Chest. 2017, 151:193-203. 10.1016\/j.chest.2016.10.010","journal-title":"Chest"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2010.261","article-title":"Stereotactic body radiation therapy for inoperable early stage lung cancer","volume":"303","author":"Timmerman R","year":"2010","unstructured":"Timmerman R, Paulus R, Galvin J, et al.. Stereotactic body radiation therapy for inoperable early stage lung cancer. JAMA. 2010, 303:1070-6. 10.1001\/jama.2010.261","journal-title":"JAMA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000524","article-title":"Stereotactic ablative radiation therapy for the treatment of early-stage non-small-cell lung cancer: CEPO review and recommendations","volume":"10","author":"Boily G","year":"2015","unstructured":"Boily G, Filion \u00c9, Rakovich G, et al.. Stereotactic ablative radiation therapy for the treatment of early-stage non-small-cell lung cancer: CEPO review and recommendations. J Thorac Oncol. 2015, 10:872-82. 10.1097\/JTO.0000000000000524","journal-title":"J Thorac Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2204.0023","article-title":"Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology","volume":"22","author":"Riely GJ","year":"2024","unstructured":"Riely GJ, Wood DE, Ettinger DS, et al.. Non-small cell lung cancer, version 4.2024, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2024, 22:249-74. 10.6004\/jnccn.2204.0023","journal-title":"J Natl Compr Canc Netw"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22763","article-title":"Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC)","volume":"110","author":"Hof H","year":"2007","unstructured":"Hof H, Muenter M, Oetzel D, Hoess A, Debus J, Herfarth K. Stereotactic single-dose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC). Cancer. 2007, 110:148-55. 10.1002\/cncr.22763","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2013.01.004","article-title":"Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review","volume":"106","author":"Senthi S","year":"2013","unstructured":"Senthi S, Haasbeek CJ, Slotman BJ, Senan S. Outcomes of stereotactic ablative radiotherapy for central lung tumours: a systematic review. Radiother Oncol. 2013, 106:276-82. 10.1016\/j.radonc.2013.01.004","journal-title":"Radiother Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2012.01.018","article-title":"Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer","volume":"83","author":"Matsuo Y","year":"2012","unstructured":"Matsuo Y, Shibuya K, Nakamura M, et al.. Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer. Int J Radiat Oncol Biol Phys. 2012, 83:e545-9. 10.1016\/j.ijrobp.2012.01.018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2018.11.036","article-title":"Chest wall toxicity after stereotactic body radiation therapy: a pooled analysis of 57 studies","volume":"103","author":"Ma JT","year":"2019","unstructured":"Ma JT, Liu Y, Sun L, et al.. Chest wall toxicity after stereotactic body radiation therapy: a pooled analysis of 57 studies. Int J Radiat Oncol Biol Phys. 2019, 103:843-50. 10.1016\/j.ijrobp.2018.11.036","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.21037\/atm-21-6256","article-title":"Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis","volume":"10","author":"Zhang R","year":"2022","unstructured":"Zhang R, Kang J, Ren S, Xing L, Xu Y. Comparison of stereotactic body radiotherapy and radiofrequency ablation for early-stage non-small cell lung cancer: a systematic review and meta-analysis. Ann Transl Med. 2022, 10:104. 10.21037\/atm-21-6256","journal-title":"Ann Transl Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.04.056","article-title":"Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial","volume":"80","author":"Bral S","year":"2011","unstructured":"Bral S, Gevaert T, Linthout N, et al.. Prospective, risk-adapted strategy of stereotactic body radiotherapy for early-stage non-small-cell lung cancer: results of a Phase II trial. Int J Radiat Oncol Biol Phys. 2011, 80:1343-9. 10.1016\/j.ijrobp.2010.04.056","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref15","unstructured":"National Institutes of Health, National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE) Version 5.0. (2025). Accessed. May 1, 2025: http:\/\/dctd.cancer.gov."},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201308-1483ST","article-title":"An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias","volume":"188","author":"Travis WD","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM, et al.. An official American Thoracic Society\/European Respiratory Society statement: update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013, 188:733-48. 10.1164\/rccm.201308-1483ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.21037\/tro.2019.03.03","article-title":"Stereotactic body radiotherapy for lung cancer in patients with interstitial lung disease","volume":"3","author":"Onishi H","year":"2019","unstructured":"Onishi H. Stereotactic body radiotherapy for lung cancer in patients with interstitial lung disease. Ther Radiol Oncol. 2019, 3:3. 10.21037\/tro.2019.03.03","journal-title":"Ther Radiol Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2017.03.010","article-title":"Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review","volume":"98","author":"Chen H","year":"2017","unstructured":"Chen H, Senan S, Nossent EJ, Boldt RG, Warner A, Palma DA, Louie AV. Treatment-related toxicity in patients with early-stage non-small cell lung cancer and coexisting interstitial lung disease: a systematic review. Int J Radiat Oncol Biol Phys. 2017, 98:622-31. 10.1016\/j.ijrobp.2017.03.010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2020.11.020","article-title":"Idiopathic pulmonary fibrosis: current knowledge, future perspectives and its importance in radiation oncology","volume":"155","author":"T\u00fcrkkan G","year":"2021","unstructured":"T\u00fcrkkan G, Willems Y, Hendriks LE, et al.. Idiopathic pulmonary fibrosis: current knowledge, future perspectives and its importance in radiation oncology. Radiother Oncol. 2021, 155:269-77. 10.1016\/j.radonc.2020.11.020","journal-title":"Radiother Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2023.7269","article-title":"Stereotactic radiation therapy in early non-small cell lung cancer and interstitial lung disease: a nonrandomized clinical trial","volume":"10","author":"Palma DA","year":"2024","unstructured":"Palma DA, Bahig H, Hope A, et al.. Stereotactic radiation therapy in early non-small cell lung cancer and interstitial lung disease: a nonrandomized clinical trial. JAMA Oncol. 2024, 10:575-82. 10.1001\/jamaoncol.2023.7269","journal-title":"JAMA Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-24-1813","article-title":"Navigating restriction from interstitial lung disease (ILD) with stereotactic ablative radiotherapy (SABR) in early-stage non-small cell lung cancer: soaring beyond the current treatment paradigm","volume":"14","author":"Kassardjian AA","year":"2025","unstructured":"Kassardjian AA, Malhotra J, Lee P. Navigating restriction from interstitial lung disease (ILD) with stereotactic ablative radiotherapy (SABR) in early-stage non-small cell lung cancer: soaring beyond the current treatment paradigm. Transl Cancer Res. 2025, 14:11-5. 10.21037\/tcr-24-1813","journal-title":"Transl Cancer Res"},{"key":"ref22","unstructured":"WMA General Assembly. WMA - The World Medical Association-WMA Declaration of Helsinki - Ethical Principles for Medical Research Involving Human Participants. (2025). Accessed. November 1, 2025: https:\/\/www.wma.net\/policies-post\/wma-declaration-of-helsinki\/."},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.39335.541782.AD","article-title":"Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"335","author":"von Elm E","year":"2007","unstructured":"von Elm E, Altman DG, Egger M, Pocock SJ, G\u00f8tzsche PC, Vandenbroucke JP. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. BMJ. 2007, 335:806-8. 10.1136\/bmj.39335.541782.AD","journal-title":"BMJ"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.03.081","article-title":"RECIST 1.1\u2014update and clarification: from the RECIST committee","volume":"62","author":"Schwartz LH","year":"2016","unstructured":"Schwartz LH, Liti\u00e8re S, de Vries E, et al.. RECIST 1.1\u2014update and clarification: from the RECIST committee. Eur J Cancer. 2016, 62:132-7. 10.1016\/j.ejca.2016.03.081","journal-title":"Eur J Cancer"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken MM","year":"1982","unstructured":"Oken MM, Creech RH, Tormey DC, Horton J, Davis TE, McFadden ET, Carbone PP. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol. 1982, 5:649-55. 10.1097\/00000421-198212000-00014","journal-title":"Am J Clin Oncol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201908-1590ST","article-title":"Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement","volume":"200","author":"Graham BL","year":"2019","unstructured":"Graham BL, Steenbruggen I, Miller MR, et al.. Standardization of spirometry 2019 update. An official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med. 2019, 200:e70-88. 10.1164\/rccm.201908-1590ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201807-1255ST","article-title":"Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline","volume":"198","author":"Raghu G","year":"2018","unstructured":"Raghu G, Remy-Jardin M, Myers JL, et al.. Diagnosis of idiopathic pulmonary fibrosis. An official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2018, 198:e44-68. 10.1164\/rccm.201807-1255ST","journal-title":"Am J Respir Crit Care Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-156-10-201205150-00004","article-title":"A multidimensional index and staging system for idiopathic pulmonary fibrosis","volume":"156","author":"Ley B","year":"2012","unstructured":"Ley B, Ryerson CJ, Vittinghoff E, et al.. A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med. 2012, 156:684-91. 10.7326\/0003-4819-156-10-201205150-00004","journal-title":"Ann Intern Med"},{"key":"ref29","unstructured":"UK SABR Consortium, SABR Consensus Guidelines for the UK. 2021 Update (Version 6.1). (2021). Accessed: December 16, 2025: https:\/\/www.sabr.org.uk\/wp-content\/uploads\/2019\/04\/SABRconsortium-guidelines-2019-v6.1.0.pdf."},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.clon.2022.02.010","article-title":"UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy","volume":"34","author":"Diez P","year":"2022","unstructured":"Diez P, Hanna GG, Aitken KL, et al.. UK 2022 consensus on normal tissue dose-volume constraints for oligometastatic, primary lung and hepatocellular carcinoma stereotactic ablative radiotherapy. Clin Oncol (R Coll Radiol). 2022, 34:288-300. 10.1016\/j.clon.2022.02.010","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.14744\/scie.2023.45577","article-title":"Factors affecting survival in early-stage lung cancer other than subtype and stage","volume":"34","author":"Cimenoglu B","year":"2023","unstructured":"Cimenoglu B, Duman S, Erus S, Ozkan B, Kara M, Demirhan R, Toker A. Factors affecting survival in early-stage lung cancer other than subtype and stage. South Clin Istanb Eurasia. 2023, 34:365-70. 10.14744\/scie.2023.45577","journal-title":"South Clin Istanb Eurasia"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-59649-5","article-title":"Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis","volume":"14","author":"Lee H","year":"2024","unstructured":"Lee H, Kim SY, Park YS, Choi SM, Lee JH, Park J. Prognostic implication of 1-year decline in diffusing capacity in newly diagnosed idiopathic pulmonary fibrosis. Sci Rep. 2024, 14:8857. 10.1038\/s41598-024-59649-5","journal-title":"Sci Rep"},{"key":"ref33","article-title":"Diffusing capacity of the lungs for carbon monoxide","author":"Goldin J","year":"2024","unstructured":"Goldin J, Cascella M. Diffusing capacity of the lungs for carbon monoxide. StatPearls. StatPearls Publishing, Treasure Island, FL; 2024."},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1378\/chest.06-3096","article-title":"Natural history of stage I non-small cell lung cancer: implications for early detection","volume":"132","author":"Raz DJ","year":"2007","unstructured":"Raz DJ, Zell JA, Ou SH, Gandara DR, Anton-Culver H, Jablons DM. Natural history of stage I non-small cell lung cancer: implications for early detection. Chest. 2007, 132:193-9. 10.1378\/chest.06-3096","journal-title":"Chest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/443541-outcomes-and-toxicity-of-stereotactic-radiotherapy-in-non-small-cell-lung-cancer-patients-with-interstitial-lung-disease-a-multicentre-cohort-study","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,26]],"date-time":"2025-12-26T14:23:57Z","timestamp":1766759037000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/443541-outcomes-and-toxicity-of-stereotactic-radiotherapy-in-non-small-cell-lung-cancer-patients-with-interstitial-lung-disease-a-multicentre-cohort-study"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,26]]},"references-count":34,"URL":"https:\/\/doi.org\/10.7759\/cureus.100124","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12,26]]}}}